• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Results From the OPTIMAL Trial Five Years Out: Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation for Prolapse?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • The original Operations and Pelvic Muscle Training in the Management of Apical Support Loss (OPTIMAL) study provided 2-year outcomes in women undergoing vaginal apical prolapse repair with midurethral sling for stress urinary incontinence
    • There were no significant differences between surgical intervention with either sacrospinous ligament fixation (SSLF) or uterosacral ligament vaginal vault suspension (ULS)
  • Jelovsek et al. (JAMA 2018) provide the results from Extended-OPTIMAL study which provides 5-year follow up and assesses the efficacy of
    • Uterosacral ligament suspension (ULS) vs. sacrospinous ligament fixation (SSLF)
    • Perioperative behavioral therapy and pelvic floor muscle training (BPMT) for vaginal apical prolapse

METHODS:

  • Multi-centered randomized clinical trial
  • 5 year follow up of the OPTIMAL trial
  • Participants: Women going for planned surgery for stage 2 to 4 prolapse, vaginal bulge symptoms, descent of the uterus or vaginal apex at least halfway into the vagina, stress urinary incontinence symptoms, and objective demonstration of stress incontinence by office or urodynamic testing in the previous 12 months
  • Patients either received
    • BPMT or usual care
    • Surgical intervention (USL or SSLF)
  • Primary surgical outcome was time to surgical failure
  • Surgical failure was defined as
    • Apical descent greater than 1/3 of total vaginal length or anterior or posterior vaginal wall beyond the hymen or retreatment for prolapse
    • Bothersome bulge symptoms
  • Primary behavioral outcomes were time to anatomic failure and Pelvic Organ Prolapse Distress Inventory scores (range, 0-300)

RESULTS:

  • 244 (86%) patients completed the extended trial
    • BMPT (n = 186); Usual care (n= 188); ULS(n=188); SSLF(n=186)
  • By year 5, the estimated surgical failure rate was
    • 61.5% in the ULS group and 70.3% in the SSLF group
    • Adjusted difference was not significant
  • The estimated anatomic failure rate was
    • 45.6% in the BPMT group and 47.2% in the usual care group
    • Adjusted difference was not significant
  • Improvements in Pelvic Organ Prolapse Distress Inventory scores were
    • ~59.4 in the BPMT group and ~61.8 in the usual care group
    • Adjusted mean difference was not significant

CONCLUSION:

  • Surgical failure was not different between ULS and SSLF
  • Anatomic success and symptom scores were not different between usual care and BMPT
  • Compared with outcomes at 2 years, rates of surgical failure increased during the follow-up period; however, prolapse symptoms scores remained improved

Learn More – Primary Sources:

Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Mesh and Pelvic Organ Prolapse: ACOG Practice Advisory & ACOG/AUGS Recommendations 
Robotic vs Vaginal vs Open Surgery for Vaginal Prolapse – How Do They Compare?
What is the Best Approach to Repair Vaginal Vault Prolapse following Hysterectomy?
Is Pelvic Muscle Strengthening Effective Following Pelvic Surgery for Prolapse and Incontinence?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site